Aposense Pipeline: From Platform to Products
Aposense Pipeline: From Platform to Products
Aposense Pipeline: From Platform to Products
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Summary<br />
• Core Core Capabilities<br />
Capabilities<br />
– Novel platform technologies<br />
– Full drug development capabilities<br />
– New Product Generation Process<br />
• <strong>Pipeline</strong><br />
<strong>Pipeline</strong><br />
– Lead clinical program: Apop<strong>to</strong>sis Imaging (ML-10) near completion of phase 2<br />
– Growing & maturing pre-clinical portfolio: 3 new drugs, major unmet needs<br />
– New compounds continuously added by application of platform<br />
• Corporate Infrastructure<br />
– Experienced board and management team<br />
– Strong financial position
Change language